Position Statements and publications

The British Oncology Pharmacy Association work in consultation with professionals, both inside and outside the pharmacy profession, to produce publications and position statements on certain topics. In addition BOPA publish a newsletter several times a year, circulated in hard copy to all members and archived on the website.

Publications may reflect work of one or more individuals on an area relating to cancer pharmacy, access to which is considered by the BOPA committee, to be of benefit to the membership.

Position statements are sometimes considered useful in the clarification of certain contentious pharmaceutical issues relating to cancer. These statements are often provided by the committee (and are endorsed by the Network Pharmacists Forum in some instances) in response to concerns from the membership. They are intended to provide guidance for members and also encourage a common response. The position statements on this web-site are not legally binding and represent a consensus view. This area of the web-site also shows collated responses to comments on consultation documents.

  • BOPA 2010 Membership Plan

  • Competancies to support verification of prescriptions for SACT v1.3.pdf (80.52 Kb) (Responses to the consultation on these standards are available here: Consultation on BOPA verification competancies.doc (39.94 Kb))
  • Standards for Clinical Pharmacy Verification of Prescriptions for Cancer Medicines Jan 2010
    Feedack from Consultation on BOPA standards for Verification 8.1.10
    Guidance to Support BOPA Standards for Clinical Pharmacy Verification of Prescriptions for Cancer Medicines (April 2010)

  • CNPF: Report into Uptake of Patient Access Schemes (November 2009)

  • Joint BOPA & CNPF: Guidance For The Development Of Pharmacist Non Medical Prescribing And Review Of Patients Receiving Anticancer Medicines (July 2009)

  • Joint BOPA & CNPF Response: Response to Chemotherapy Services in England. The NCAG report (February 2009)

  • BOPA Response: Guidance on NHS patients who wish to pay for additional private care (January 2009)

  • How to implement Dose Banded Chemotherapy. (August 2008)

  • Position Statement on Risk Sharing Schemes in Oncology (March 2008)

  • Response to consultation comments

  • Guidance on The Safe Handling Of Monoclonal Antibody (Mab) Products - 4th edition


  • Position Statement on Access to Unlicensed Drugs Outside of Clinical Trials (May 2006)


  • Response to comments received on the consultation document on Access to Investigations outside of Clinical Trials


  • Position Statement on the Packaging of Oral Cytotoxic Medicines for Clinical Trials (July 2005)


  • Competency Framework (Dec 2004)


  • Position Statement on Safe Practice and the Pharmaceutical Care of Patients receiving Oral Anti-cancer Chemotherapy (Jan 2004)


  • The NHS Cancer Plan and the Pharmacy Contribution to Cancer Care
  • Login
    I forgot my password